XSHG
603968
Market cap274mUSD
Jul 10, Last price
9.34CNY
1D
2.41%
1Q
-28.15%
Jan 2017
-61.50%
IPO
-39.78%
Name
Nantong Acetic Acid Chemical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nantong Acetic Acid Chemical Co., Ltd., founded in 1959 and operating from its headquarters in Nantong, China, is a significant entity involved in the production and global distribution of a diverse range of chemical compounds. The company's extensive product catalog features a wide array of food and animal feed additives, including sorbic acid, potassium sorbate, dehydroacetic acid, sodium dehydroacetate, nicotinic acid, nicotinamide, and clopidol. It also manufactures and supplies critical intermediates essential for pharmaceutical and pesticide production, such as methyl acetoacetate, ethyl acetoacetate, 2-cyanopyridine, 3-cyanopyridine, and 4-cyanopyridine. For the coloration sector, the firm provides a comprehensive selection of dye and pigment intermediates, notably acetoacetanilide, 2-methylacetoacetanilide, N-acetoacetyl-4-methylaniline, o-acetoacetaniside, p-acetoacetaniside, p-acetophenetidide, 2,4-dimethylacetoacetanilide, acetoacetic-2,5-dimethoxyanilide, 1-(p-tolyl)-3-methyl-5-pyrazolone, 1-phenyl-3-methyl-5-pyrazolone, 5-acetoacetlamino benzimdazolone, naphthol AS-G, 4-chloro-2,5-dimethoxyacetoacetanilide, and N,N'-(1,4-phenylene)bis(acetoacetamide). Furthermore, its offerings encompass fundamental organic chemical raw materials like diketene, acetonitrile, and crotonaldehyde. Beyond its standard lines, Nantong Acetic Acid Chemical also caters to specific client requirements through custom synthesis services, delivering bespoke products such as sodium acetate anhydrous, N-methylacetoacetamide, 2-isopropyl-4-methyl-6-pyrimidinone, 3-methyl-1-(4-sulfophenyl)-5-pyrazolone, 1-(3-sulfophenyl)-3-methyl-5-pyrazolone, 1-(3'-chlorophenyl)-3-methyl-5-pyrazolone, and 1-(2-chlorophenyl)-3-methyl-5-pyrazolone.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||